May 05, 2020
Acesion Pharma Strengthens Clinical Team With Key Appointments
Dec 10, 2019
Correvio Announces Outcome Of FDA Advisory Committee Meeting Reviewing Brinavess(TM) For The Treatment Of Recent Onset Atrial Fibrillation
Dec 10, 2019
Correvio Stock Trading Halted Today; FDA Advisory Committee Meeting To Discuss Brinavess(TM) For Recent Onset Atrial Fibrillation
Nov 21, 2019
Thrombosis Research Institute (TRI) Launches Innovative Risk Calculator for Predicting Stroke, Major Bleeding and Mortality in Atrial Fibrillation Over Two Years
Nov 18, 2019
Correvio Announces Presentation of New Brinavess(TM) Spectrum Data at the American Heart Association 2019 Annual Meeting
Nov 04, 2019
Correvio Announces FDA Advisory Committee Meeting to Review Brinavess(TM) for Recent Onset Atrial Fibrillation
Sep 03, 2019
Correvio Announces Presentation Of Brinavess® Spectrum Data At The European Society Of Cardiology 2019 Congress
Aug 12, 2019
Correvio Announces Brinavess® Spectrum Data to be Presented at the European Society of Cardiology 2019 Congress
Mar 20, 2019
Correvio Announces Presentation Of Brinavess® Data At The American College Of Cardiology 2019 Annual Meeting
Feb 07, 2019
Correvio Announces Presentation Of Brinavess Data At Belgian Society Of Cardiology 2019 Annual Congress
Oct 29, 2018
Correvio Announces Brinavess Eligibility for Patent Extension
Oct 23, 2018
Correvio Announces Intention to Re-File Brinavess® NDA in Second Quarter 2019
Sep 05, 2018
Correvio Reports Preliminary Data Collected from >2,000 Brinavess® Treatment Episodes in EU Post-Authorization Safety Study
Aug 28, 2018
Real-world Evidence From GARFIELD-AF Shows Superior Reduction in Mortality With Non-vitamin K Antagonists Oral Anticoagulants (NOACs) vs. Vitamin K Antagonists (VKAs) in Newly Diagnosed Atrial Fibrillation
Aug 20, 2018
Thrombosis Research Institute (TRI) to Announce New Real-World Insights in Atrial Fibrillation at ESC Congress 2018
Aug 16, 2018
Correvio Announces EU Survey Data Demonstrating Brinavess Successfully Avoided Hospitalization in 85% of Patients
Aug 14, 2018
Correvio Announces Brinavess® Selected as Potentially Eligible for Priority Review in China
Jul 10, 2018
Huntington Hospital Performs First WATCHMAN(TM) Left Atrial Appendage Closure to Treat Patients with Atrial Fibrillation
Apr 17, 2018
Cardiome Completes Enrollment in the Post Approval Safety Study SPECTRUM Evaluating Brinavess®
Apr 09, 2018
Houston Methodist The Woodlands Hospital is first hospital in The Woodlands to offer an alternative to long-term warfarin medication to reduce the risk of stroke